Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MKL | CB |
|---|---|---|
| Price | $1,718.18 | $329.90 |
| Change today | ▲ 0.33% | ▲ 1.43% |
| Market cap | $21.29B | $127.28B |
| Return, 3 months | -10.4% | -5.9% |
| Return, year to date | -20.1% | +6.7% |
| Return, 1 year | -8.9% | +18.7% |
| P/E (TTM) | 9.5 | 11.7 |
| P/B | 1.1 | 1.7 |
| P/E percentile vs own 5y | 35th | 48th |
| Dividend yield | – | 1.19% |
| Revenue growth (YoY, latest qtr) | +17.8% | +7.2% |
| Net profit growth (YoY) | +75.1% | -3.9% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 13.7% | 18.0% |
| Return on equity | 12.6% | 15.5% |
| Analyst target vs. price | +13.5% | +13.4% |
| Analyst buy share | 0% | 39% |
| RSI (14) | 28 | 37 |
| 30-day volatility | 13.0% | 14.9% |
| Max drawdown, 1 year | -21.9% | -9.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
